“Severe Injection Site Reactions After Subcutaneous Administration of Sayana®: A Retrospective, Post-Marketing Analysis of WHO and Swiss Spontaneous Pharmacovigilance Reports”. Swiss Medical Weekly, vol. 147, no. 1920, May 2017, p. w14432, https://doi.org/10.4414/smw.2017.14432.